$50.73
0.40% day before yesterday
Nasdaq, Nov 01, 09:00 pm CET
ISIN
US03209R1032
Symbol
AMPH

Amphastar Pharmaceuticals Inc Target price 2024 - Analyst rating & recommendation

Amphastar Pharmaceuticals Inc Classifications & Recommendation:

Buy
60%
Hold
40%

Amphastar Pharmaceuticals Inc Price Target

Target Price $59.00
Price $50.73
Potential
Number of Estimates 4
4 Analysts have issued a price target Amphastar Pharmaceuticals Inc 2025 . The average Amphastar Pharmaceuticals Inc target price is $59.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 3 Analysts recommend Amphastar Pharmaceuticals Inc to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Amphastar Pharmaceuticals Inc stock has an average upside potential 2025 of . Most analysts recommend the Amphastar Pharmaceuticals Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 644.40 746.56
29.14% 15.85%
EBITDA Margin 37.47% 41.19%
37.24% 9.93%
Net Margin 19.75% 26.39%
15.71% 33.59%

5 Analysts have issued a sales forecast Amphastar Pharmaceuticals Inc 2024 . The average Amphastar Pharmaceuticals Inc sales estimate is

$747m
Unlock
. This is
4.72% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$768m 7.73%
Unlock
, the lowest is
$726m 1.87%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $644m 29.14%
2024
$747m 15.85%
Unlock
2025
$819m 9.69%
Unlock
2026
$912m 11.32%
Unlock
2027
$1.1b 18.43%
Unlock

4 Analysts have issued an Amphastar Pharmaceuticals Inc EBITDA forecast 2024. The average Amphastar Pharmaceuticals Inc EBITDA estimate is

$307m
Unlock
. This is
7.76% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$334m 17.05%
Unlock
, the lowest is
$283m 0.96%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $241m 77.23%
2024
$307m 27.34%
Unlock
2025
$347m 12.89%
Unlock
2026
$417m 20.27%
Unlock
2027
$510m 22.05%
Unlock

EBITDA Margin

2023 37.47% 37.24%
2024
41.19% 9.93%
Unlock
2025
42.39% 2.91%
Unlock
2026
45.79% 8.02%
Unlock
2027
47.19% 3.06%
Unlock

3 Amphastar Pharmaceuticals Inc Analysts have issued a net profit forecast 2024. The average Amphastar Pharmaceuticals Inc net profit estimate is

$197m
Unlock
. This is
28.13% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$211m 36.94%
Unlock
, the lowest is
$182m 18.47%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $127m 49.43%
2024
$197m 54.74%
Unlock
2025
$214m 8.45%
Unlock
2026
$236m 10.70%
Unlock

Net Margin

2023 19.75% 15.71%
2024
26.39% 33.59%
Unlock
2025
26.09% 1.14%
Unlock
2026
25.94% 0.57%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 2.60 4.02
49.43% 54.62%
P/E 12.61
EV/Sales 3.84

3 Analysts have issued a Amphastar Pharmaceuticals Inc forecast for earnings per share. The average Amphastar Pharmaceuticals Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$4.02
Unlock
. This is
28.03% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$4.30 36.94%
Unlock
, the lowest is
$3.72 18.47%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $2.60 49.43%
2024
$4.02 54.62%
Unlock
2025
$4.36 8.46%
Unlock
2026
$4.83 10.78%
Unlock

P/E ratio

Current 16.16 29.43%
2024
12.61 21.97%
Unlock
2025
11.63 7.77%
Unlock
2026
10.50 9.72%
Unlock

Based on analysts' sales estimates for 2024, the Amphastar Pharmaceuticals Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.03 14.26%
2024
3.84 4.62%
Unlock
2025
3.50 8.84%
Unlock
2026
3.15 10.17%
Unlock
2027
2.66 15.56%
Unlock

P/S ratio

Current 3.46 14.09%
2024
3.31 4.51%
Unlock
2025
3.02 8.84%
Unlock
2026
2.71 10.17%
Unlock
2027
2.29 15.57%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today